ESR1 and neoplasm: ESR1 (p. V392I, 0.23% VAF) and ERBB2 (p. V104M, 0.59% VAF) mutations detected in the FFPE tumour were undetected in plasma suggesting that these were subclonal mutations not detectable in ctDNA.